Header Logo

Connection

ROY F CHEMALY to Immunocompromised Host

Back to Details
This is a "connection" page, showing publications ROY F CHEMALY has written about Immunocompromised Host.
ROY F CHEMALY
Connection Strength
6.150
Immunocompromised Host
  1. The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings. Clin Microbiol Infect. 2021 10; 27(10):1379-1380.
    View in: PubMed
    Score: 0.553
  2. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis. 2021 Jan 11; 21(1):46.
    View in: PubMed
    Score: 0.534
  3. Update on infection control practices in cancer hospitals. CA Cancer J Clin. 2018 09; 68(5):340-355.
    View in: PubMed
    Score: 0.449
  4. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
    View in: PubMed
    Score: 0.405
  5. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res. 2016 10; 134:58-62.
    View in: PubMed
    Score: 0.394
  6. The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy. 2014 Nov; 34(11):1220-5.
    View in: PubMed
    Score: 0.343
  7. CMV prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 08 07; 371(6):576-7.
    View in: PubMed
    Score: 0.342
  8. Antimicrobial de-escalation in cancer patients. Infection. 2012 Apr; 40(2):223-4; author reply 229-30.
    View in: PubMed
    Score: 0.283
  9. Viral pneumonias in immunocompromised adult hosts. J Intensive Care Med. 2010 Nov-Dec; 25(6):307-26.
    View in: PubMed
    Score: 0.261
  10. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert Opin Pharmacother. 2010 Aug; 11(11):1901-13.
    View in: PubMed
    Score: 0.259
  11. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.
    View in: PubMed
    Score: 0.191
  12. Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line? Clin Microbiol Infect. 2024 Mar; 30(3):270-275.
    View in: PubMed
    Score: 0.161
  13. Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes. Clin Microbiol Infect. 2022 10; 28(10):1319-1320.
    View in: PubMed
    Score: 0.147
  14. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient. Scand J Infect Dis. 2002; 34(2):149-51.
    View in: PubMed
    Score: 0.143
  15. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin Infect Dis. 2021 08 02; 73(3):e773-e781.
    View in: PubMed
    Score: 0.139
  16. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol. 2020 04; 15:389-400.
    View in: PubMed
    Score: 0.126
  17. Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 11; 25(11):e321-e330.
    View in: PubMed
    Score: 0.121
  18. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies. Haematologica. 2019 07; 104(7):1322-1331.
    View in: PubMed
    Score: 0.120
  19. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 04 08; 68(8):1420-1426.
    View in: PubMed
    Score: 0.118
  20. Paramyxovirus infections in hematopoietic cell transplant recipients. Curr Opin Infect Dis. 2018 12; 31(6):542-552.
    View in: PubMed
    Score: 0.115
  21. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994.
    View in: PubMed
    Score: 0.114
  22. The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis. 2016 Dec 12; 16(1):750.
    View in: PubMed
    Score: 0.101
  23. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract. 2016 Apr; 22(2):325-31.
    View in: PubMed
    Score: 0.087
  24. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 May 08; 370(19):1781-9.
    View in: PubMed
    Score: 0.084
  25. Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett. 2014 Jan 01; 342(1):1-8.
    View in: PubMed
    Score: 0.080
  26. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33.
    View in: PubMed
    Score: 0.072
  27. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011 Mar 10; 117(10):2755-63.
    View in: PubMed
    Score: 0.066
  28. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
    View in: PubMed
    Score: 0.063
  29. Palivizumab: where to from here? Expert Opin Biol Ther. 2009 Jan; 9(1):139-47.
    View in: PubMed
    Score: 0.058
  30. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006 Sep; 85(5):278-287.
    View in: PubMed
    Score: 0.049
  31. Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis. 2024 03 20; 78(3):775-784.
    View in: PubMed
    Score: 0.042
  32. Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer. 2003 May 15; 97(10):2576-87.
    View in: PubMed
    Score: 0.039
  33. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105.
    View in: PubMed
    Score: 0.030
  34. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol. 2018 01; 90(1):50-60.
    View in: PubMed
    Score: 0.027
  35. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013. J Infect Dis. 2015 Feb 15; 211(4):582-9.
    View in: PubMed
    Score: 0.021
  36. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis. 2007 Sep; 9(3):256-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.